- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | RESONANCE HEALTH LIMITED: Trading Halt | 1 | ASX | ||
| Di | RESONANCE HEALTH LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| RESONANCE HEALTH Aktie jetzt für 0€ handeln | |||||
| Di | RESONANCE HEALTH LIMITED: Liver Fibrosis Device - Clinical Trial Results - Webinar | 3 | ASX | ||
| 30.09. | RESONANCE HEALTH LIMITED: AGM Date & Director Nomination Closing Date | 1 | ASX | ||
| 24.09. | RESONANCE HEALTH LIMITED: Change in Substantial Holding | - | ASX | ||
| 17.09. | Resonance Health Partners with UK CRO to Include SaMD Services in Global Clinical Trials | 1 | smallcaps.com.au | ||
| 17.09. | Daily Special: Resonance Health, AML3D, Lion Energy, Latrobe Magnesium, Marquee Resources | 3 | Finance News Network | ||
| 17.09. | RESONANCE HEALTH LIMITED: Global Strategic Alliance & MSA with Image Analysis Group | 2 | ASX | ||
| 31.08. | RESONANCE HEALTH LIMITED: Appendix 4G & Corporate Governance Statement | - | ASX | ||
| 28.08. | RESONANCE HEALTH LIMITED: FY26 Full Year Results & Investor Webinar | 2 | ASX | ||
| 28.08. | RESONANCE HEALTH LIMITED: FY26 Full Year Results & FY27 Guidance Investor Presentation | 1 | ASX | ||
| 28.08. | RESONANCE HEALTH LIMITED: Appendix 4E, Full Year Statutory Accounts & Annual Report | - | ASX | ||
| 19.08. | RESONANCE HEALTH LIMITED: FY26 Full Year Results Webinar | 1 | ASX | ||
| 12.08. | RESONANCE HEALTH LIMITED: Cessation of Quarterly Reporting | 1 | ASX | ||
| 24.07. | Resonance Health Improves Cash Position as Clinical Trial Pipeline Expands | 3 | smallcaps.com.au | ||
| 24.07. | RESONANCE HEALTH LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 15.07. | RESONANCE HEALTH LIMITED: Change of Director's Interest Notice - Simon Panton | - | ASX | ||
| 09.06. | RESONANCE HEALTH LIMITED: Liver Fibrosis Device Progress & FY26 Portfolio Webinar | - | ASX | ||
| 27.05. | RESONANCE HEALTH LIMITED: Change of Director's Interest Notice - Dr David Fuller | - | ASX | ||
| 05.05. | Resonance Health Upgrades FY26 Profit Guidance by 30% Amid Strong Operational Performance | 1 | Finance News Network |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,100 | +1,75 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat Fresenius nach Gesprächen mit der Investor-Relations-Abteilung mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Die Aktien stehen zudem auf der... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,11 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,860 | +0,24 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,460 | +3,27 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GENEDX | 56,08 | -0,12 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| ALIGNMENT HEALTHCARE | 8,060 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| PRIVIA HEALTH GROUP | 22,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| HEARTFLOW | 56,74 | +0,05 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| CARL ZEISS MEDITEC | 35,540 | +1,25 % | 12 Prozent bessere Testleistung: Wie ZEISS das Zusammenspiel von Brillenglas und Gehirn untersucht | ||
| BILLIONTOONE | 107,65 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CONCENTRA GROUP | 39,290 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| LIFESTANCE HEALTH GROUP | 12,940 | +0,08 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PACS GROUP | 47,660 | +0,06 % | Omega Healthcare transitions 32 Florida facilities to PACS Group | ||
| GERRESHEIMER | 31,340 | -2,06 % | Gerresheimer-Aktie: Trotz der deutlichen Kurserholung noch einsteigen? | Die Gerresheimer-Aktie entwickelt sich seit dem Kurseinbruch im Februar sehr erfreulich. Notierte sie damals noch bei etwa 16 €, steht sie am Montag aktuell bei rund 30,10 €. Damit hat sich der Kurs... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,390 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen |
RESONANCE HEALTH LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RESONANCE HEALTH LIMITED finden Sie auf Wallstreet Online.